CION INVESTMENT CORP - CION 7 1/2 12/30/29 (CICB) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:CICB • US17259U3032

25.27 USD
-0.06 (-0.24%)
Last: Feb 5, 2026, 04:10 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CICB. CICB was compared to 238 industry peers in the Capital Markets industry. CICB may be in some trouble as it scores bad on both profitability and health. CICB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year CICB was profitable.
  • In the past year CICB had a positive cash flow from operations.
  • CICB had positive earnings in 4 of the past 5 years.
  • In multiple years CICB reported negative operating cash flow during the last 5 years.
CICB Yearly Net Income VS EBIT VS OCF VS FCFCICB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

  • CICB's Return On Assets of 1.38% is on the low side compared to the rest of the industry. CICB is outperformed by 64.71% of its industry peers.
  • The Return On Equity of CICB (3.36%) is worse than 65.97% of its industry peers.
  • CICB has a Return On Invested Capital of 3.99%. This is comparable to the rest of the industry: CICB outperforms 56.30% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CICB is below the industry average of 7.28%.
Industry RankSector Rank
ROA 1.38%
ROE 3.36%
ROIC 3.99%
ROA(3y)3.06%
ROA(5y)3.03%
ROE(3y)6.88%
ROE(5y)6.43%
ROIC(3y)4%
ROIC(5y)3.85%
CICB Yearly ROA, ROE, ROICCICB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

  • CICB has a worse Profit Margin (10.59%) than 62.60% of its industry peers.
  • In the last couple of years the Profit Margin of CICB has declined.
  • The Operating Margin of CICB (38.16%) is better than 69.33% of its industry peers.
  • In the last couple of years the Operating Margin of CICB has declined.
  • With a Gross Margin value of 42.94%, CICB perfoms like the industry average, outperforming 44.54% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CICB has declined.
Industry RankSector Rank
OM 38.16%
PM (TTM) 10.59%
GM 42.94%
OM growth 3Y-7.11%
OM growth 5Y-2.62%
PM growth 3Y-43.77%
PM growth 5Y-12.21%
GM growth 3Y-8.4%
GM growth 5Y-1.98%
CICB Yearly Profit, Operating, Gross MarginsCICB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

2

2. Health

2.1 Basic Checks

  • CICB has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for CICB has been reduced compared to 5 years ago.
  • Compared to 1 year ago, CICB has a worse debt to assets ratio.
CICB Yearly Shares OutstandingCICB Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CICB Yearly Total Debt VS Total AssetsCICB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • Based on the Altman-Z score of 0.81, we must say that CICB is in the distress zone and has some risk of bankruptcy.
  • CICB has a Altman-Z score of 0.81. This is comparable to the rest of the industry: CICB outperforms 50.84% of its industry peers.
  • CICB has a debt to FCF ratio of 21.36. This is a negative value and a sign of low solvency as CICB would need 21.36 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 21.36, CICB is in line with its industry, outperforming 55.88% of the companies in the same industry.
  • A Debt/Equity ratio of 1.40 is on the high side and indicates that CICB has dependencies on debt financing.
  • CICB's Debt to Equity ratio of 1.40 is on the low side compared to the rest of the industry. CICB is outperformed by 67.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.4
Debt/FCF 21.36
Altman-Z 0.81
ROIC/WACCN/A
WACCN/A
CICB Yearly LT Debt VS Equity VS FCFCICB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • CICB has a Current Ratio of 0.37. This is a bad value and indicates that CICB is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CICB's Current ratio of 0.37 is on the low side compared to the rest of the industry. CICB is outperformed by 78.15% of its industry peers.
  • CICB has a Quick Ratio of 0.37. This is a bad value and indicates that CICB is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CICB has a Quick ratio of 0.37. This is in the lower half of the industry: CICB underperforms 77.73% of its industry peers.
Industry RankSector Rank
Current Ratio 0.37
Quick Ratio 0.37
CICB Yearly Current Assets VS Current LiabilitesCICB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

1

3. Growth

3.1 Past

  • CICB shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.67%.
  • CICB shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.01% yearly.
  • The Revenue has decreased by -3.78% in the past year.
  • Measured over the past years, CICB shows a small growth in Revenue. The Revenue has been growing by 4.65% on average per year.
EPS 1Y (TTM)-1.67%
EPS 3Y-32.85%
EPS 5Y-7.01%
EPS Q2Q%85%
Revenue 1Y (TTM)-3.78%
Revenue growth 3Y17.08%
Revenue growth 5Y4.65%
Sales Q2Q%32.01%

3.2 Future

  • Based on estimates for the next years, CICB will show a very negative growth in Earnings Per Share. The EPS will decrease by -15.37% on average per year.
  • CICB is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -11.11% yearly.
EPS Next Y2.84%
EPS Next 2Y-12.33%
EPS Next 3Y-15.37%
EPS Next 5YN/A
Revenue Next Year-4.07%
Revenue Next 2Y-11.23%
Revenue Next 3Y-11.11%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CICB Yearly Revenue VS EstimatesCICB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
CICB Yearly EPS VS EstimatesCICB Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

2

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 14.28, the valuation of CICB can be described as correct.
  • CICB's Price/Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 28.25, CICB is valued a bit cheaper.
  • The Price/Forward Earnings ratio is 18.79, which indicates a rather expensive current valuation of CICB.
  • The rest of the industry has a similar Price/Forward Earnings ratio as CICB.
  • When comparing the Price/Forward Earnings ratio of CICB to the average of the S&P500 Index (27.50), we can say CICB is valued slightly cheaper.
Industry RankSector Rank
PE 14.28
Fwd PE 18.79
CICB Price Earnings VS Forward Price EarningsCICB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • The rest of the industry has a similar Price/Free Cash Flow ratio as CICB.
Industry RankSector Rank
P/FCF 25.86
EV/EBITDA N/A
CICB Per share dataCICB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • CICB's earnings are expected to decrease with -15.37% in the coming years. This may justify a cheaper valuation.
PEG (NY)5.04
PEG (5Y)N/A
EPS Next 2Y-12.33%
EPS Next 3Y-15.37%

3

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 4.29%, CICB is a good candidate for dividend investing.
  • CICB's Dividend Yield is comparable with the industry average which is at 6.02.
  • CICB's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 4.29%

5.2 History

  • The dividend of CICB decreases each year by -7.50%.
  • CICB does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)-7.5%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 303.09% of the earnings are spent on dividend by CICB. This is not a sustainable payout ratio.
  • CICB's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP303.09%
EPS Next 2Y-12.33%
EPS Next 3Y-15.37%
CICB Yearly Income VS Free CF VS DividendCICB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 100M -100M
CICB Dividend Payout.CICB Dividend Payout, showing the Payout Ratio.CICB Dividend Payout.PayoutRetained Earnings

CION INVESTMENT CORP - CION 7 1/2 12/30/29

NYSE:CICB (2/5/2026, 4:10:04 PM)

25.27

-0.06 (-0.24%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-06
Earnings (Next)03-12
Inst Owners38.98%
Inst Owner ChangeN/A
Ins Owners0.46%
Ins Owner ChangeN/A
Market Cap1.31B
Revenue(TTM)244.92M
Net Income(TTM)25.95M
Analysts47.5
Price Target28.78 (13.89%)
Short Float %0.01%
Short Ratio0.61
Dividend
Industry RankSector Rank
Dividend Yield 4.29%
Yearly Dividend1.67
Dividend Growth(5Y)-7.5%
DP303.09%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)55.49%
Min EPS beat(2)-5.79%
Max EPS beat(2)116.78%
EPS beat(4)2
Avg EPS beat(4)27.96%
Min EPS beat(4)-5.79%
Max EPS beat(4)116.78%
EPS beat(8)5
Avg EPS beat(8)18.98%
EPS beat(12)8
Avg EPS beat(12)20.52%
EPS beat(16)11
Avg EPS beat(16)18.06%
Revenue beat(2)1
Avg Revenue beat(2)21.26%
Min Revenue beat(2)-3.98%
Max Revenue beat(2)46.51%
Revenue beat(4)3
Avg Revenue beat(4)13.09%
Min Revenue beat(4)-3.98%
Max Revenue beat(4)46.51%
Revenue beat(8)7
Avg Revenue beat(8)10.78%
Revenue beat(12)10
Avg Revenue beat(12)11.33%
Revenue beat(16)13
Avg Revenue beat(16)9.86%
PT rev (1m)0.34%
PT rev (3m)0.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.8%
EPS NY rev (1m)0%
EPS NY rev (3m)30.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.69%
Revenue NY rev (1m)2.68%
Revenue NY rev (3m)11.44%
Valuation
Industry RankSector Rank
PE 14.28
Fwd PE 18.79
P/S 5.33
P/FCF 25.86
P/OCF 25.86
P/B 1.69
P/tB 1.69
EV/EBITDA N/A
EPS(TTM)1.77
EY7%
EPS(NY)1.35
Fwd EY5.32%
FCF(TTM)0.98
FCFY3.87%
OCF(TTM)0.98
OCFY3.87%
SpS4.74
BVpS14.95
TBVpS14.95
PEG (NY)5.04
PEG (5Y)N/A
Graham Number24.4
Profitability
Industry RankSector Rank
ROA 1.38%
ROE 3.36%
ROCE 5.05%
ROIC 3.99%
ROICexc 4%
ROICexgc 4%
OM 38.16%
PM (TTM) 10.59%
GM 42.94%
FCFM 20.62%
ROA(3y)3.06%
ROA(5y)3.03%
ROE(3y)6.88%
ROE(5y)6.43%
ROIC(3y)4%
ROIC(5y)3.85%
ROICexc(3y)4.07%
ROICexc(5y)3.91%
ROICexgc(3y)4.07%
ROICexgc(5y)3.91%
ROCE(3y)5.06%
ROCE(5y)4.88%
ROICexgc growth 3Y5.57%
ROICexgc growth 5Y0.49%
ROICexc growth 3Y5.57%
ROICexc growth 5Y0.49%
OM growth 3Y-7.11%
OM growth 5Y-2.62%
PM growth 3Y-43.77%
PM growth 5Y-12.21%
GM growth 3Y-8.4%
GM growth 5Y-1.98%
F-Score4
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 1.4
Debt/FCF 21.36
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.07
Cash Conversion N/A
Profit Quality 194.62%
Current Ratio 0.37
Quick Ratio 0.37
Altman-Z 0.81
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.67%
EPS 3Y-32.85%
EPS 5Y-7.01%
EPS Q2Q%85%
EPS Next Y2.84%
EPS Next 2Y-12.33%
EPS Next 3Y-15.37%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.78%
Revenue growth 3Y17.08%
Revenue growth 5Y4.65%
Sales Q2Q%32.01%
Revenue Next Year-4.07%
Revenue Next 2Y-11.23%
Revenue Next 3Y-11.11%
Revenue Next 5YN/A
EBIT growth 1Y-5.58%
EBIT growth 3Y8.76%
EBIT growth 5Y1.91%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y124.44%
FCF growth 3YN/A
FCF growth 5Y-6.89%
OCF growth 1Y124.44%
OCF growth 3YN/A
OCF growth 5Y-6.89%

CION INVESTMENT CORP - CION 7 1/2 12/30/29 / CICB FAQ

What is the ChartMill fundamental rating of CION INVESTMENT CORP - CION 7 1/2 12/30/29 (CICB) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CICB.


What is the valuation status for CICB stock?

ChartMill assigns a valuation rating of 2 / 10 to CION INVESTMENT CORP - CION 7 1/2 12/30/29 (CICB). This can be considered as Overvalued.


Can you provide the profitability details for CION INVESTMENT CORP - CION 7 1/2 12/30/29?

CION INVESTMENT CORP - CION 7 1/2 12/30/29 (CICB) has a profitability rating of 2 / 10.


Can you provide the financial health for CICB stock?

The financial health rating of CION INVESTMENT CORP - CION 7 1/2 12/30/29 (CICB) is 2 / 10.


How sustainable is the dividend of CION INVESTMENT CORP - CION 7 1/2 12/30/29 (CICB) stock?

The dividend rating of CION INVESTMENT CORP - CION 7 1/2 12/30/29 (CICB) is 3 / 10 and the dividend payout ratio is 303.09%.